Patrys
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 24 Jan 2025
- Reported shorts
- 39K
- Shares on issue
- 2.057B
Patrys (PAB) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $9.0KM (source: ASX (Markit))vs $828.5KM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 6 Oct 2026
- NPAT
- −$3.4MM (source: ASX (Markit))vs −$3.0M (FY25)
- ASX (Markit), as at 6 Oct 2026
- EPS (basic)
- n/avs n/a (FY25)
- Rev YoY
- n/mFY
- EPS YoY
- n/aFY
- ASX (Markit)
Summary of Annual Report - 30 June 2025, 28 Sep 2026
Patrys Limited reported a net loss of $3.4 million for the year ended 30 June 2026, widening from a $3.0 million loss in the prior year. No dividend was declared. The company advanced its RLS-2202 program for delirium towards a Phase 1A trial and continued development of its deoxymab antibody platform, but highlighted risks around future funding and product development.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −37,982.1%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 6 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $9.0KM (source: ASX (Markit)) | $828.5KM (source: ASX (Markit)) | $1.4MM (source: ASX (Markit)) | $2.9MM (source: ASX (Markit)) |
| Operating income | n/a | −$3.5M | −$4.9M | −$10.0M |
| EBITDA | n/a | −$3.5M | −$4.9M | −$9.9M |
| EBIT | n/a | −$3.5M | −$4.9M | −$10.0M |
| Pretax income | n/a | −$3.0M | −$3.5M | −$7.1M |
| Tax | n/a | $0 | $0 | $0 |
| NPAT | −$3.4MM (source: ASX (Markit)) | −$3.0M | −$3.5M | −$7.1M |
| Net interest income | n/a | $21.3K | $109.1K | $76.9K |
| Shares | n/a | 3.01B | 2.62B | 2.62B |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Appendix 4E Variance ReportAnnual Results28 Sep 2026via asx_announcements
- Annual Report - 30 June 2025Annual Report28 Sep 2026via asx_announcements
- Appendix 4E - Preliminary Final ReportAnnual Results31 Aug 2026via asx_announcements
- Appendix 4C - Quarterly - 30 June 2026Quarterly Report22 Jul 2026via asx_announcements
- Appendix 4C - Quarterly - 31 March 2026 - UpdatedQuarterly Report15 May 2026via asx_announcements
- Appendix 4C - Quarterly - 31 March 2026Quarterly Report30 Apr 2026via asx_announcements
- Appendix 4D - Half Year Accounts - 31 December 2025Half Year Results26 Feb 2026via asx_announcements
- Appendix 4C - Quarterly - 31 December 2025Quarterly Report30 Jan 2026via asx_announcements
- Appendix 4C - Quarterly - 30 September 2025Quarterly Report30 Oct 2025via asx_announcements
- Annual Report - 30 June 2025Annual Report5 Sep 2025via asx_announcements
Showing 10 of 92 reports